Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
6.14
-0.47 (-7.11%)
At close: Jul 13, 2026, 4:00 PM EDT
6.00
-0.14 (-2.28%)
After-hours: Jul 13, 2026, 7:00 PM EDT
Company Description
Basel Medical Group Ltd provides healthcare services in Singapore.
The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments.
It also provides health screening services, mental health, woman’s health, and general practice services.
In addition, its services include consultation, medical diagnosis, and medical and surgical treatments.
The company was incorporated in 2023 and is headquartered in Singapore.
Basel Medical Group Ltd
| Country | Singapore |
| Founded | 2001 |
| IPO Date | Feb 25, 2025 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 82 |
| CEO | Yen Feng Chhoa |
Contact Details
Address: Gleneagles Medical Centre, Unit No. 02-10/11 Singapore, 258499 Singapore | |
| Phone | 65 6291 9188 |
| Website | baselmedical.com |
Stock Details
| Ticker Symbol | BMGL |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | SGD |
| IPO Price | $4.00 |
| CIK Code | 2004489 |
| CUSIP Number | G0864B111 |
| ISIN Number | VGG0864B1114 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yen Feng Chhoa M.D. | Chief Executive Officer |
| Keng Leong Fung | Executive Chairman of the Board |
| Chun How Neo | Interim Chief Financial Officer |
| Boon Chye Tan | Chief Commercial Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 10, 2026 | 6-K | Report of foreign issuer |
| Jun 26, 2026 | 6-K | Report of foreign issuer |
| Jun 10, 2026 | 6-K | Report of foreign issuer |
| Jun 5, 2026 | 6-K | Report of foreign issuer |
| Mar 30, 2026 | 6-K | Report of foreign issuer |
| Mar 24, 2026 | 6-K | Report of foreign issuer |
| Mar 13, 2026 | 20-F/A | Filing |
| Jan 23, 2026 | 6-K | Report of foreign issuer |
| Jan 21, 2026 | 6-K | Report of foreign issuer |
| Dec 1, 2025 | 6-K | Report of foreign issuer |